These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12061320)

  • 1. Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
    Hirose Y; Masaki Y; Sugai S
    Eur J Haematol; 2002 Feb; 68(2):112-6. PubMed ID: 12061320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic findings in untreated patients with essential thrombocythemia.
    Panani AD
    In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study.
    Sessarego M; Defferrari R; Dejana AM; Rebuttato AM; Fugazza G; Salvidio E; Ajmar F
    Cancer Genet Cytogenet; 1989 Nov; 43(1):57-65. PubMed ID: 2790773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in PTPN11 may drive leukemic transformation in a case of essential thrombocythemia.
    Guo BB; Liang J; Allcock RJN; Mirzai B; Augustson B; Howman R; Fuller KA; Erber WN
    Leuk Lymphoma; 2018 Jan; 59(1):245-248. PubMed ID: 28587547
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement.
    Paolini R; Bonaldi L; Bianchini E; Ramazzina E; Cella G
    Eur J Haematol; 2003 Dec; 71(6):466-9. PubMed ID: 14703699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential thrombocythemia and leukemic transformation.
    Sedlacek SM; Curtis JL; Weintraub J; Levin J
    Medicine (Baltimore); 1986 Nov; 65(6):353-64. PubMed ID: 3465986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation--a brief review of recent literature.
    Shibata K; Shimamoto Y; Suga K; Sano M; Matsuzaki M; Yamaguchi M
    Acta Haematol; 1994; 91(2):84-8. PubMed ID: 8023650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early blastic transformation of a myeloproliferative disorder with t(8;21) and progressive aberrations of chromosome 8.
    Fasanaro A; Paone G; Silvestri I; Marottoli V; Cimino R; Ferrara F
    Cancer Genet Cytogenet; 1994 Jul; 75(2):106-10. PubMed ID: 8055472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential thrombocythemia and acute leukemia.
    Ferrari D; Ticozzelli G; De Vizzi M; Corigliano P; De Vizzi G
    Haematologica; 1993; 78(6):401-2. PubMed ID: 8175035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome.
    Stoll DB; Peterson P; Exten R; Laszlo J; Pisciotta AV; Ellis JT; White P; Vaidya K; Bozdech M; Murphy S
    Am J Hematol; 1988 Feb; 27(2):77-83. PubMed ID: 3422539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple granulocytic sarcomas in essential thrombocythemia.
    Tanaka Y; Nagai Y; Mori M; Fujita H; Togami K; Kurata M; Matsushita A; Maeda A; Nagai K; Tanaka K; Takahashi T
    Int J Hematol; 2006 Dec; 84(5):413-6. PubMed ID: 17189221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of inv(3)(q21q26) with essential thrombocythemia in transformation.
    Villalón C; Talavera M; Sordo MT; García-Sagredo JM; Lopez J; San Román C; Ferro MT
    Cancer Genet Cytogenet; 2008 Jul; 184(2):122-3. PubMed ID: 18617063
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
    Furgerson JL; Vukelja SJ; Baker WJ; O'Rourke TJ
    Am J Hematol; 1996 Feb; 51(2):137-40. PubMed ID: 8579054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
    Gangat N; Tefferi A; Thanarajasingam G; Patnaik M; Schwager S; Ketterling R; Wolanskyj AP
    Eur J Haematol; 2009 Jul; 83(1):17-21. PubMed ID: 19236446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hydroxyurea leukemogenic in essential thrombocythemia?
    Tefferi A
    Blood; 1998 Aug; 92(4):1459-60; author reply 1460-1. PubMed ID: 9694740
    [No Abstract]   [Full Text] [Related]  

  • 17. Translocation t(4; 6)(q21; q27) in a case of primary thrombocythaemia in transformation.
    Krsnik I; Ferro T; García Suárez J; Vázquez Mazariego Y; Cabello P
    Clin Lab Haematol; 2001 Aug; 23(4):259-60. PubMed ID: 11683789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.
    Paulsson K; Johansson B
    Pathol Biol (Paris); 2007 Feb; 55(1):37-48. PubMed ID: 16697122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea.
    Tabata M; Imagawa S; Tarumoto T; Ohmine K; Hatake K; Miura Y; Ozawa K
    Jpn J Clin Oncol; 2000 Jul; 30(7):310-2. PubMed ID: 11007164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.